Sign in

CIK 0000946644

  • Non-accelerated filer
  • Smaller reporting company

AIM ImmunoTech Inc.

Sign in to watch
Ticker
AIM
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
520845822
Phone
+1 352-448-7797
Business address
2117 SW HIGHWAY 484, OCALA, FL, 32801
Former names
AIM ImmunoTech Inc., HEMISPHERX BIOPHARMA INC
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Open-market buy CEO,Pres,Exec Vice Chairman bought 30,000 shares at $0.13 ($3,966)
  15. 4/A Open-market buy CEO,Pres,Exec Vice Chairman bought 40,000 shares at an average $0.16 ($6,310)
  16. 4/A Open-market buy CEO,Pres,Exec Vice Chairman bought 30,000 shares at $0.16 ($4,890)
  17. 4 Open-market buy CEO,Pres,Exec Vice Chairman bought 40,000 shares at an average $0.16 ($6,310)
  18. 4 Open-market buy CEO,Pres,Exec Vice Chairman bought 30,000 shares at $0.16 ($4,890)
  19. 4 Derivatives Options or other derivatives
  20. 4 Open-market buy CEO bought 25,000 shares at $0.18 ($4,488)

Page 19 of 31 · 616 filings